Skip to main content

Table 3 Factors associated in multivariate analysis with RFPN in the worldwide population (P3)

From: Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

 

Low haptoglobin

Low ApoA1

High ApoA1

Low A2M

High A2M

Risk for FibroTest

False Positive

False Positive

False Negative

False Negative

False Positive

Number of patients

1,590

118

732

419

427

Range

0.01-0.08 g/L

0.10-0.41 g/L

2.51-6.97 g/L

0.10-0.80 g/L

5.90-9.68 g/L

Factor (n)

Odds Ratio (95% CI) P value 1

   

Analytical factor

     

Last 3 years of test

0.76 (0.68-0.84) P < 10-5

NS

NS

NS

NS

> 10,000 tests

0.44 ((0.39-0.50) P < 10-5

NS

0.48 ((0.39-0.50) P < 10-5

NS

NS

Non analytical factor

     

Residency

     

   Western Europe

NS

NS

NS

NS

NS

   North Africa

NS

NS

NS

NS

NS

   North America

0.05 (0.01-0.20) P = 0.00005

NS

NS

NS

NS

   Eastern Europe

NS

NS

NS

22.44 (5.55-90.85) P < 10-4

NS

HIV center

3.97 (2.88-5.48) P < 10-5

NS

NS

NS

NS

Age > 50 years

0.63 (0.57-0.70) P < 10-4

NS

1.86 (1.60-1.86) P < 10-5

NS

1.56 (1.29-1.90) P = 10-4

Male gender

1.30 (1.18-1.45) P < 10-4

NS

0.34 (0.29-0.40) P < 10-5

2.6 (2.07-3.28) P < 10-5

NS

Reference center

5.35 (4.67-6.13) P < 10-5

2.61 (1.66-4.13) P = 0.00003

1.84 (1.39-2.45) P < 10-5

1.83 (1.36-2.47) P = 0.00008

NS

  1. 1 Only odds ratio with P value lower or equal to 0.0001 were considered significant